Painful Diabetic Neuropathy – Epidemiology – Mature Markets Data
The total number of prevalent cases of PDN across the countries under study will increase by 31% from 9.9 million in 2016 to 13 million in 2036.
We expect the age-specific proportions of PDN in the diabetic population to remain constant over the 20-year period based on the lack of evidence suggesting changes in risk factors associated with PDN.
Painful Diabetic Neuropathy - Epidemiology - Mature Markets Data
Prevalence of Painful Diabetic Neuropathy per 1,000 People Aged 20+ in 2017 and 2037
Relative Sizes of the Contributing Factors to the Trend in Prevalent Cases of Painful Diabetic Neuropathy over the Next 20 Years
Total Prevalent Cases of Painful Diabetic Neuropathy
Diagnosed Prevalent Cases of Painful Diabetic Neuropathy
Drug-Treated Prevalent Cases of Painful Diabetic Neuropathy
Studies Included in the Analysis of Painful Diabetic Neuropathy
Studies Excluded from the Analysis of Painful Diabetic Neuropathy
Risk/Protective Factors for Painful Diabetic Neuropathy
Sunali D. Goonesekera, S.M.
Sunali Goonesekera, S.M., is a senior epidemiologist at Clarivate. Previously, Ms. Goonesekera conducted epidemiological research on racial/ethnic disparities in metabolic diseases at the New England Research Institute and lead-authored two manuscripts. She has contributed to multiple publications in peer-reviewed journals in epidemiology and the biological sciences. She holds a master’s degree in epidemiology from the Harvard School of Public Health and a B.A. in biology (Honors) from Dartmouth College.
Wouter van der Pluijm, M.P.H.
Wouter van der Pluijm, M.P.H., is a senior epidemiologist at DRG, part of Clarivate. Prior to joining DRG, he worked for the Washtenaw County Public Health Department on the epidemiology and public health surveillance teams, studying the West Nile virus, as well as depression and drug abuse in the county. He holds an M.P.H. in epidemiology from the University of Michigan.